Literature DB >> 23299052

Role of leptin and central nervous system melanocortins in obesity hypertension.

Alexandre A da Silva1, Jussara M do Carmo, John E Hall.   

Abstract

PURPOSE OF REVIEW: Obesity is a major worldwide health problem. Excess weight gain is the most significant preventable cause of increased blood pressure (BP) in patients with essential hypertension and increases the risk for cardiovascular and renal diseases. Our goal is to review the mechanisms that link obesity with hypertension, with special emphasis on the role of leptin and the brain melanocortin system in driving sympathetic activation in obesity. RECENT
FINDINGS: Despite increased interest in obesity as a major risk for developing hypertension, the precise mechanisms linking excess weight gain with increases in BP are still elusive. Current evidence suggests that increased sympathetic nervous system (SNS) activity contributes to impaired renal-pressure natriuresis and sodium retention in obesity. Recent findings indicate that the adipocyte-derived hormone, leptin, activates brain centers that regulate SNS activity through a melanocortin-system-dependent pathway. The interaction of leptin and the brain melanocortin system represents an important area of research to further our understanding of the mechanisms leading to sympathetic activation in obesity.
SUMMARY: Sympathetic overactivity is an important link between excess weight gain and increased BP. Hormones and cytokines secreted by the adipose tissue that interact with neural pathways (e.g. melanocortin system) appear to play a key role in contributing to sympathetic activation in obesity and represent potential new targets for therapies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23299052      PMCID: PMC3905446          DOI: 10.1097/MNH.0b013e32835d0c05

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  36 in total

Review 1.  Central nervous system control of food intake.

Authors:  M W Schwartz; S C Woods; D Porte; R J Seeley; D G Baskin
Journal:  Nature       Date:  2000-04-06       Impact factor: 49.962

2.  Inhibition of NO synthesis enhances chronic cardiovascular and renal actions of leptin.

Authors:  J J Kuo; O B Jones; J E Hall
Journal:  Hypertension       Date:  2001-02       Impact factor: 10.190

3.  Chronic cardiovascular and renal actions of leptin: role of adrenergic activity.

Authors:  Megan Carlyle; Oscar B Jones; Jay J Kuo; John E Hall
Journal:  Hypertension       Date:  2002-02       Impact factor: 10.190

4.  Chronic effects of centrally administered adiponectin on appetite, metabolism and blood pressure regulation in normotensive and hypertensive rats.

Authors:  Mirian Bassi; Jussara M do Carmo; John E Hall; Alexandre A da Silva
Journal:  Peptides       Date:  2012-06-27       Impact factor: 3.750

Review 5.  The kidney, hypertension, and obesity.

Authors:  John E Hall
Journal:  Hypertension       Date:  2003-01-20       Impact factor: 10.190

6.  Antihypertensive effect of alpha- and beta-adrenergic blockade in obese and lean hypertensive subjects.

Authors:  M R Wofford; D C Anderson; C A Brown; D W Jones; M E Miller; J E Hall
Journal:  Am J Hypertens       Date:  2001-07       Impact factor: 2.689

Review 7.  Mechanisms of obesity-associated cardiovascular and renal disease.

Authors:  John E Hall; Errol D Crook; Daniel W Jones; Marion R Wofford; Patricia M Dubbert
Journal:  Am J Med Sci       Date:  2002-09       Impact factor: 2.378

8.  Disruption of neural signal transducer and activator of transcription 3 causes obesity, diabetes, infertility, and thermal dysregulation.

Authors:  Qian Gao; Michael J Wolfgang; Susanne Neschen; Katsutaro Morino; Tamas L Horvath; Gerald I Shulman; Xin-Yuan Fu
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-22       Impact factor: 11.205

Review 9.  Obesity and hypertension: two epidemics or one?

Authors:  Kevin P Davy; John E Hall
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2004-05       Impact factor: 3.619

10.  Overweight and obesity as determinants of cardiovascular risk: the Framingham experience.

Authors:  Peter W F Wilson; Ralph B D'Agostino; Lisa Sullivan; Helen Parise; William B Kannel
Journal:  Arch Intern Med       Date:  2002-09-09
View more
  31 in total

Review 1.  Selective leptin resistance revisited.

Authors:  Allyn L Mark
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-07-24       Impact factor: 3.619

Review 2.  The impacts of obesity on the cardiovascular and renal systems: cascade of events and therapeutic approaches.

Authors:  Zohreh Soltani; Vaughn Washco; Stephen Morse; Efrain Reisin
Journal:  Curr Hypertens Rep       Date:  2015-02       Impact factor: 5.369

Review 3.  Control of energy balance by the brain renin-angiotensin system.

Authors:  Kristin E Claflin; Justin L Grobe
Journal:  Curr Hypertens Rep       Date:  2015-05       Impact factor: 5.369

Review 4.  Brain to bone: What is the contribution of the brain to skeletal homeostasis?

Authors:  Anna Idelevich; Roland Baron
Journal:  Bone       Date:  2018-05-16       Impact factor: 4.398

Review 5.  Role of the brain melanocortins in blood pressure regulation.

Authors:  Jussara M do Carmo; Alexandre A da Silva; Zhen Wang; Taolin Fang; Nicola Aberdein; Cecilia E Perez de Lara; John E Hall
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-03-06       Impact factor: 5.187

6.  Leptin beyond the lipostat: key component of blood pressure regulation.

Authors:  Christine M Kusminski; Philipp E Scherer
Journal:  Circ Res       Date:  2015-04-10       Impact factor: 17.367

Review 7.  Pathophysiology and Potential Non-Pharmacologic Treatments of Obesity or Kidney Disease Associated Refractory Hypertension.

Authors:  Thierry H Le Jemtel; William Richardson; Rohan Samson; Abhishek Jaiswal; Suzanne Oparil
Journal:  Curr Hypertens Rep       Date:  2017-02       Impact factor: 5.369

8.  Role of melanocortin 4 receptor in hypertension induced by chronic intermittent hypoxia.

Authors:  Jussara M do Carmo; Alexandre A da Silva; Sydney P Moak; Fernanda S da Silva; Frank T Spradley; John E Hall
Journal:  Acta Physiol (Oxf)       Date:  2018-12-23       Impact factor: 6.311

9.  Chronic hyperleptinemia results in the development of hypertension in pregnant rats.

Authors:  Ana C Palei; Frank T Spradley; Joey P Granger
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-03-11       Impact factor: 3.619

Review 10.  Animal models in obesity and hypertension.

Authors:  Gabriella Segal-Lieberman; Talma Rosenthal
Journal:  Curr Hypertens Rep       Date:  2013-06       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.